Office of Management HN612 Office of Management HN612 Office of Science Policy and Communications HN614 Office of Science Policy and Communications HN614 Division of Neurosciences and Behav ID: 847999
Download Pdf The PPT/PDF document "National Institute on Drug Abuse" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1 National Institute on Drug Abuse Office
National Institute on Drug Abuse Office of Management (HN612) Office of Management (HN612) Office of Science Policy and Communications (HN614) Office of Science Policy and Communications (HN614) Division of Neurosciences and Behavior (HN65) Division of Neurosciences and Behavior (HN65) Intramural Research Program (HN64) Intramural Research Program (HN64) Division of Epidemiology, Services and Prevention Research (HN63) Division of Epidemiology, Services and Prevention Research (HN63) • Provides a national leadership and conducts and supports biomedical and behavioral research, health services research, resear ch training, and health information dissemination with respect to the prevention of drug abuse and treatment of drug abusers; • Plans, conducts, fosters, and supports a comprehensive program of research and research training relating to the causes, prev ention, treatment, patterns, and consequences of drug abuse and addiction, through research performed in its own laboratories and through contra cts and
2 grants to scientific institutions
grants to scientific institutions and to individuals; • Supports training in fundamental sciences and clinical disciplines relating to drug abuse by individual and institutional res earch training awards; • Coordinates with other research Institutes and with other Federal health and other agencies in activities relevant to drug ab use and addiction; • Conducts and fosters health information dissemination activities, including the collection and dissemination of research find ings and related educational materials for health professionals and the lay public; • Coordinates with institutions and professional associations and with international, national, State, and voluntary agencies w orking in these areas; and • Collaborates with the Substance Abuse and Mental Health Services Administration on services research issues as well as on oth er programmatic issues. Office of the Director (HN61) Office of the Director (HN61) Division of Extramural Research (HN69) Division of Extramural Research (HN69) Cen
3 ter for the Clinical Trials Network (HN
ter for the Clinical Trials Network (HN67) Center for the Clinical Trials Network (HN67) Division of Therapeutics & Medical Consequences (HN66) Division of Therapeutics & Medical Consequences (HN66) Office of the Director Office of Management (HN612) Office of Science Policy and Communications (HN614) Financial Management Branch (HN6122) Policy Branch/Secton (61282) Contract Management Branch Blue (61288) Contract Management Branch Green (61289) Information Resource Management Branch (HN6126) Communications Branch (HN6143) Office of the Director (HN61) Red Section 1 (2) Contract Management Branch Red (61287) Administrative Management Branch (HN6125) Office of Acquisitions (HN6128) Science Policy Branch (HN6145) Red Section 2 (3) Red Section 3 (4) Blue Section 1 (2) Blue Section 2 (3) Blue Section 3 (4) Green Section 1 (2) Green Section 2 (3) Green Section 3 (4) Management Analysis Branch (HN612A) Digital Communications Section (HN61432) Division of Epidemiology, Services and Prevention Research Epidemiology Re
4 search Branch (HN637) Epidemiology Rese
search Branch (HN637) Epidemiology Research Branch (HN637) Prevention Research Branch (HN635) Prevention Research Branch (HN635) Services Research Branch (HN638) Services Research Branch (HN638) Office of the Director (HN63) Office of the Director (HN63) Intramural Research Program Administrative Management Branch (HN642) Administrative Management Branch (HN642) Office of the Clinical Director (HN646) Office of the Clinical Director (HN646) Molecular Targets and Medication Discovery Branch (HN645) Molecular Targets and Medication Discovery Branch (HN645) Cellular Neurobiology Research Branch (HN64C) Cellular Neurobiology Research Branch (HN64C) Clinical Pharmacology and Therapeutics Research Branch (HN644) Clinical Pharmacology and Therapeutics Research Branch (HN644) Integrative Neuroscience Research Branch (HN64H) Integrative Neuroscience Research Branch (HN64H) Behavioral Neuroscience Research Branch (HN64D) Behavioral Neuroscience Research Branch (HN64D) Office of the Director (HN641) Office of the Director (HN64
5 1) Treatment Section (2) Treatment Secti
1) Treatment Section (2) Treatment Section (2) Neurobiology of Addiction Section (5) Neurobiology of Addiction Section (5) Integrative Neurobiology Section (7) Integrative Neurobiology Section (7) Medicinal Chemistry Section (4) Medicinal Chemistry Section (4) Neurobiology of Relapse Section (5) Neurobiology of Relapse Section (5) Neuronal Ensembles of Addiction Section (6) Neuronal Ensembles of Addiction Section (6) Neuronal Networks Section (6) Neuronal Networks Section (6) Synaptic Plasticity Section (6) Synaptic Plasticity Section (6) Preclinical Pharmacology Section (3) Preclinical Pharmacology Section (3) Neurocircuitry Motivation Section (4) Neurocircuitry Motivation Section (4) Drug Design and Synthesis Section (5) Drug Design and Synthesis Section (5) Neuropsychopharmacology Section (6) Neuropsychopharmacology Section (6) Behavioral Neurophysiology Neuroscience Section (7) Behavioral Neurophysiology Neuroscience Section (7) Molecular Neuropsychiatry Section (3) Molecular Neuropsychiatry Section (3) C
6 ellular Pathobiology Section (3) Cellula
ellular Pathobiology Section (3) Cellular Pathobiology Section (3) Neuroimaging Research Branch (HN647) Neuroimaging Research Branch (HN647) Molecular Neurophsychiatry Research Branch (HN64E) Molecular Neurophsychiatry Research Branch (HN64E) Magnetic Resonance Imaging and Spectroscopy Section (2) Magnetic Resonance Imaging and Spectroscopy Section (2) Cognitive and Affective Neuroscience of Addition Section (3) Cognitive and Affective Neuroscience of Addition Section (3) Translational Addiction Medicine Branch (HN64J) Translational Addiction Medicine Branch (HN64J) Clinical Psychoneuroendocrinology and Neuropsychopharmacology (2) Electrophysiology Section (8) Electrophysiology Section (8) Division of Neurosciences and Behavioral Genetics, Epigenetics & Development Neuroscience Branch (HN652) Integrative Neuroscience Branch (HN653) Behavioral & Cognitive Neuroscience Branch (HN658) Chemistry and Pharmacology Branch (HN656) Office of the Director (HN65) Division of Therapeutics & Medical Consequences Medica
7 tions Discovery and Toxicology Branch (
tions Discovery and Toxicology Branch (HN665) Medications Discovery and Toxicology Branch (HN665) Regulatory Affairs Branch (HN666) Regulatory Affairs Branch (HN666) Chemistry and Pharmaceutics Branch (HN663) Chemistry and Pharmaceutics Branch (HN663) Medical Consequences Branch (HN662) Medical Consequences Branch (HN662) Clinical/Medical Branch (HN669) Clinical/Medical Branch (HN669) Clinical Research Grants Branch (HN667) Clinical Research Grants Branch (HN667) Office of the Director (HN66) Office of the Director (HN66) Division of Extramural Research Office of Extramural Policy & Review (HN694) Office of Extramural Policy & Review (HN694) Grants Management Branch (HN692) Grants Management Branch (HN692) Office of the Director (HN691) Office of the Director (HN691) Scientific Review Branch (HN6942) Extramural Activities & Initiatives Development Branch (HN694) Extramural Activities & Initiatives Development Branch (HN694) Scientific Review Branch (HN6942) Extramural Activities & Initiatives Development Branch (HN69